Hikma Pharmaceuticals (LON:HIK) Stock Crosses Above 200 Day Moving Average – What’s Next?

Shares of Hikma Pharmaceuticals PLC (LON:HIK) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,007.93 ($25.31) and traded as high as GBX 2,198 ($27.70). Hikma Pharmaceuticals shares last traded at GBX 2,182 ($27.50), with a volume of 900,183 shares changing hands.

Analyst Ratings Changes

Separately, Berenberg Bank increased their price target on Hikma Pharmaceuticals from GBX 2,400 ($30.25) to GBX 2,560 ($32.27) and gave the company a “buy” rating in a research report on Wednesday, January 29th.

Hikma Pharmaceuticals Price Performance

The firm has a market cap of £5.99 billion, a PE ratio of 21.20, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a debt-to-equity ratio of 55.82, a current ratio of 1.66 and a quick ratio of 1.27. The business’s fifty day moving average is GBX 2,149.82 and its 200-day moving average is GBX 2,007.93.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.